Online Database of Chemicals from Around the World Search | Submit | Advertise |

Home >> Chemical Listing >> Colistimethate>> Market Analysis Reports
 

Market Analysis Reports of Colistimethate

EC Number: 232-516-9 Colistimethate sodium Chemical Report & Database
... 232-516-9 Colistimethate sodium Chemical Report & Database This Colistimethate sodium Chemical ... End User sector. The Colistimethate sodium World Consumption Report ... & Database definitions: Name: Colistimethate sodium: Colistimethate sodium Chemical Registry ...

Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020
Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H2 2020, provides an overview ...

Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H1 2020
Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H1 2020 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Resistant Pseudomonas aeruginosa Infections - Pipeline Review, H1 2020, provides an overview ...

Chronic Pulmonary Infections - Pipeline Insight, 2021
... SNG-001 ION-827359 MEDI3506 Colistimethate sodium inhaled CHF6001

Resistant Pseudomonas aeruginosa Infections (Infectious Disease) - Drugs In Development, 2021
Resistant Pseudomonas aeruginosa Infections (Infectious Disease) - Drugs In Development, 2021 SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Resistant Pseudomonas aeruginosa Infections - Drugs In Development, ...

Cystic Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Cystic Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cystic Fibrosis - Drugs In Development, 2022, provides ...




Copyright ©  chemBlink. All rights reserved. Content Disclaimer | about chemBlink | Contact